CDKN2B and neoplasm: Considerable research efforts by Xu et al. proved that E2F1 exerted its tumor-promotive effects on gastric cancer based on the regulation of TINCR transcriptional activity and the TINCR/STAU1/CDKN2B signaling pathway [39].